AstraZeneca plc buy melinda
Start price
15.11.17
/
50%
€55.11
Target price
22.03.18
€66.00
Performance (%)
-3.72%
End price
22.03.18
€53.05
Summary
This prediction ended on 22.03.18 with a price of €53.05. With a performance of -3.72%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| AstraZeneca plc | 5.065% | 5.065% | 2.896% | 12.510% |
| iShares Core DAX® | -1.283% | 4.209% | 7.084% | 64.252% |
| iShares Nasdaq 100 | -3.338% | -1.744% | 26.177% | 84.969% |
| iShares Nikkei 225® | -4.286% | -1.621% | 44.320% | 79.253% |
| iShares S&P 500 | -2.311% | -0.096% | 20.823% | 68.079% |
Comments by melinda for this prediction
In the thread AstraZeneca plc diskutieren
Arzneimittel
Astrazeneca ist ein führendes, weltweit tätiges Pharmaunternehmen. CA von therapeutischem Bereich wie folgt: - Herz-Kreislauf- und Stoffwechselerkrankungen (35,3%); - Atemwegserkrankungen (20,7%); - Onkologie (14,7%). - andere (22%): Entzündungserkrankungen
(Vom Mitglied beendet)
Stopped prediction by melinda for AstraZeneca plc
AstraZeneca plc
Start price
Target price
Perf. (%)
€72.16
11.11.18
11.11.18
€110.00
21.01.19
21.01.19
-11.24%
21.01.19
21.01.19
